Found: 12
Select item for more details and to access through your institution.
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E575, doi. 10.1002/ajh.24854
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure Response Assessment of CC-292, a Potent BTK Inhibitor, in Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 10, p. 1279, doi. 10.1002/jcph.923
- By:
- Publication type:
- Article
The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.
- Published in:
- Mycopathologia, 2016, v. 181, n. 3/4, p. 305, doi. 10.1007/s11046-015-9963-5
- By:
- Publication type:
- Article
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1172, doi. 10.1007/s00262-005-0686-1
- By:
- Publication type:
- Article
Metabolism of Non-Translatable Globin mRNAs Arising from Premature Translation Termination Codons.
- Published in:
- Annals of the New York Academy of Sciences, 1990, v. 612, n. 1, p. 55, doi. 10.1111/j.1749-6632.1990.tb24290.x
- By:
- Publication type:
- Article
Metabolism of Structurally Abnormal mRNAs Resulting from β-Thalassemia Mutations<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1985, v. 445, n. 1, p. 57, doi. 10.1111/j.1749-6632.1985.tb17175.x
- By:
- Publication type:
- Article
Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Erratum to: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Novel Therapies for Aggressive B-Cell Lymphoma.
- Published in:
- Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/302570
- By:
- Publication type:
- Article
Epidemiological characteristics in serotype 24 paediatric invasive pneumococcal disease according to an 11-year population-based study in Japan.
- Published in:
- Epidemiology & Infection, 2022, v. 150, p. 1, doi. 10.1017/S0950268822000395
- By:
- Publication type:
- Article
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 344, doi. 10.1111/j.1365-2141.2009.07626.x
- By:
- Publication type:
- Article